首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simultaneous determination of paclitaxel and lansoprazole in rat plasma by LC-MS/MS method and its application to a preclinical pharmacokinetic study of investigational PTX-LAN-PLGA nanoformulation
【24h】

Simultaneous determination of paclitaxel and lansoprazole in rat plasma by LC-MS/MS method and its application to a preclinical pharmacokinetic study of investigational PTX-LAN-PLGA nanoformulation

机译:通过LC-MS / MS法同时测定大鼠等离子体中的紫杉醇和兰沙拉唑及其在研究PTX-LAN-PLGA纳米型临床前药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

In spite of having a remarkable anti tumor activity against a wide variety of cancers, the clinical effectiveness of the major chemotherapeutic drug paclitaxel is often limited by the issues of drug resistance that hampers the therapeutic effectiveness of the drug. The combination of proton pump inhibitor with paclitaxel is an effective approach to overcome therapeutic resistance caused by the acidic microenvironment (Warburg effect) in tumor. In the present study a new simple, precise and selective liquid chromatography tandem mass spectrometry method was developed for quantification of paclitaxel and lansoprazole using esomeprazole as an internal standard and applied for the pharmacokinetic study of investigational paclitaxel - lansoprazole loaded PLGA nanoparticles. The developed method quantifies both the drugs simultaneously irrespective of their dissimilar stability concerns. The detection was exercised with multiple reaction-monitoring mode in positive ionization that yielded highly intense response of parent-product (m/z) transition pair 854.4 -> 286.1, 370.1 -> 251.9 and 346 -> 198 for paclitaxel, lansoprazole and Esomeprazole respectively. The chromatographic separation was achieved using phenomenex Kinetex 5 mu C18 100A 50 x 3.0 mm column and a gradient mobile phase combination of ammonium acetate in deionized water (pH 6.8, 2 mM, w/v) and acetonitrile spiked with formic acid (1:1000, v/v ). This method showed good linearity over a concentration range of 10-320 ng/mL and 100-3200 ng/mL with correlation coefficient (R-2) 0.98 and 0.94 for paclitaxel and lansoprazole respectively. Using liquid liquid extraction process both the drugs were extracted from rat plasma. The intra- and inter-day precision and accuracy values were within the variability limits and both the analytes were found to be stable throughout the freeze-thaw, auto-sampler, bench top and long term stability studies. The liquid chromatography tandem mass spectrometry method was successfully v
机译:尽管对各种各样的癌症具有显着的抗肿瘤活性,但主要化学治疗药物紫杉醇的临床效果通常受到耐药性的限制,妨碍了药物治疗效果。质子泵抑制剂与紫杉醇的组合是克服肿瘤中酸性微环境(Warburg效应)引起的治疗抗性的有效方法。本研究采用新的简单,精确和选择性液相色谱串联质谱法,用于使用Esomeprazole作为内标进行紫杉醇和兰辛拉唑的定量,并施用于研究紫杉醇的药代动力学研究 - LansoPrazole负载PLGA纳米粒子。开发方法同时量化了两种药物,而不管其不同的稳定性问题如何。用阳性电离中的多重反应监测模式进行检测,其分别产生高母产物(m / z)过渡对854.4-> 286.1,370.1-> 251.9和346 - > 198的高度强烈响应,分别用于紫杉醇,兰辛唑和埃斯美普拉唑198 。使用现象KINETEX 5MU C18 100A 50×3.0mm柱和乙酸铵中的乙酸铵(pH6.8,2mm,w / v)和用甲酸(1:1000 ,v / v)。该方法分别显示出浓度范围的浓度范围为10-320ng / ml和100-3200ng / ml,分别为紫杉醇和兰萨克萨唑的相关系数(R-2)0.98和0.94。使用液体萃取工艺,从大鼠等离子体中提取药物。在变化限制和日间精确和精度值中,发现分析物均在整个冻融,自动采样器,台式顶部和长期稳定性研究中稳定。液相色谱串联质谱法成功v

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号